Journal of the Neurological Sciences
Volume 206, Issue 2 , Pages 181-185 , 15 February 2003

Remyelination in multiple sclerosis

References 

  1. Allen IV. Pathology of multiple sclerosis. In:  Matthews WB editors. McAlpine's multiple sclerosis. vol. 2:Edinburgh: Churchill Livingstone; 1991;p. 341–378
  2. Prineas JW. The neuropathology of multiple sclerosis. In:  Koetsier JC editors. Handbook of clinical neurology: demyelinating diseases. Amsterdam: Elsevier; 1985;p. 213–257
  3. Lassmann H. Pathology of multiple sclerosis. In:  Compston A,  Ebers G,  Lassmann H,  McDonald I,  Matthews B,  Wekerle H editor. McAlpine's multiple sclerosis. vol. 3:London: Churchill Livingstone; 1998;p. 323–358
  4. Lassmann H, Brück W, Lucchinetti C. Heterogeneity of multiple sclerosis pathogenesis: implications for diagnosis and therapy. Trends Mol. Med. 2001;7:115–121
  5. Lucchinetti C, Brück W, Parisi J, Scheithauer B, Rodriguez M, Lassmann H. Heterogeneity of multiple sclerosis lesions: implications for the pathogenesis of demyelination. Ann. Neurol. 2000;47:707–717
  6. Marburg O. Die sogenannte akute Multiple Sklerose (Encephalomyelitis periaxialis scleroticans). Jahrb. Psychiat. Neurol. 1906;27:213–312
  7. Prineas JW, Barnard RO, Kwon EE, Sharer LR, Cho ES. Multiple sclerosis: remyelination of nascent lesions. Ann. Neurol. 1993;33:137–151
  8. Raine CS, Wu E. Multiple sclerosis: remyelination in acute lesions. J. Neuropathol. Exp. Neurol. 1993;52:199–204
  9. Prineas JW, Connell F. Remyelination in multiple sclerosis. Ann. Neurol. 1979;5:22–31
  10. Lassmann H, Brück W, Lucchinetti C, Rodriguez M. Remyelination in multiple sclerosis. Mult. Scler. 1997;3:133–136
  11. Mews I, Bergmann M, Bunkowski S, Gullotta F, Brück W. Oligodendrocyte and axon pathology in clinically silent multiple sclerosis lesions. Mult. Scler. 1998;4:55–62
  12. Prineas JW, Barnard RO, Revesz T, Kwon EE, Sharer L, Cho ES. Multiple sclerosis. Pathology of recurrent lesions. Brain. 1993;116:681–693
  13. Yao D-L, Liu X, Hudson LD, Webster Hd. Insulin-like growth factor 1 treatment reduces demyelination and up-regulates gene expression of myelin-related proteins in experimental autoimmune encephalomyelitis. Proc. Natl. Acad. Sci. U. S. A. 1995;92:6190–6194
  14. Carson MJ, Behringer RR, Brinster RL, McMorris FA. Insulin-like growth factor I increases brain growth and central nervous system myelination in transgenic mice. Neuron. 1999;10:729–740
  15. Asakura K, Rodriguez M. A unique population of circulating autoantibodies promotes central nervous system remyelination. Mult. Scler. 1998;4:217–221
  16. Blakemore WF, Chari DM, Gilson JM, Crang AJ. Modelling large areas of demyelination in the rat reveals the potential and possible limitations of transplanted glial cells for remyelination in the CNS. Glia. 2002;38:155–168
  17. Learish RD, Brüstle O, Zhang S-C, Duncan ID. Intraventricular transplantation of oligodendrocyte progenitors into a fetal myelin mutant results in widespread formation of myelin. Ann. Neurol. 1999;46:716–722
  18. Brüstle O, Jones KN, Learish RD, Karram K, Choudhary K, Wiestler OD, et al.  Embryonic stem cell-derived glial precursors: a source of myelinating transplants. Science. 1999;285:754–756
  19. Lassmann H. Comparative neuropathology of chronic experimental allergic encephalomyelitis and multiple sclerosis. Berlin Heidelberg, Germany: Springer-Verlag; 1983;
  20. Perier O, Gregoire A. Electron microscopic features of multiple sclerosis lesions. Brain. 1965;88:937–952
  21. Brück W, Schmied M, Suchanek G, Brück Y, Breitschopf H, Poser S, et al.  Oligodendrocytes in the early course of multiple sclerosis. Ann. Neurol. 1994;35:65–73
  22. Ozawa K, Suchanek G, Breitschopf H, Brück W, Budka H, Jellinger K, et al.  Patterns of oligodendroglia pathology in multiple sclerosis. Brain. 1994;117:1311–1322
  23. Brück W, Porada P, Poser S, Rieckmann P, Hanefeld F, Kretzschmar HA, et al.  Monocyte/macrophage differentiation in early multiple sclerosis lesions. Ann. Neurol. 1995;38:788–796
  24. Lucchinetti C, Brück W, Noseworthy JH. Multiple sclerosis: recent developments in neuropathology, pathogenesis, magnetic resonance imaging and treatment. Curr. Opin. Neurol. 2001;14:259–269
  25. Prineas JW, Kwon EE, Goldenberg PZ, Ilyas AA, Quarles RH, Benjamins JA, et al.  Multiple sclerosis. Oligodendrocyte proliferation and differentiation in fresh lesions. Lab. Invest. 1989;61:489–503
  26. Raine CS, Scheinberg L, Waltz JM. Multiple sclerosis. Oligodendrocyte survival and proliferation in an active established lesion. Lab. Invest. 1981;45:534–546
  27. Rodriguez M, Scheithauer BW, Forbes G, Kelly PJ. Oligodendrocyte injury is an early event in lesions of multiple sclerosis. Mayo Clin. Proc. 1993;68:627–636
  28. Lucchinetti C, Brück W, Parisi J, Scheithauer B, Rodriguez M, Lassmann H. A quantitative analysis of oligodendrocytes in multiple sclerosis lesions. A study of 113 cases. Brain. 1999;122:2279–2295
  29. Chang A, Tourtellotte WW, Rudick R, Trapp BD. Premyelinating oligodendrocytes in chronic lesions of multiple sclerosis. N. Engl. J. Med. 2002;346:165–173
  30. Wolswijk G. Oligodendrocyte precursor cells in the demyelinated spinal cord. Brain. 2002;125:338–349
  31. Wolswijk G. Oligodendrocyte survival, loss and birth in lesions of chronic-stage multiple sclerosis. Brain. 2000;123:105–115
  32. Capello E, Voskuhl RR, McFarland HF, Raine CS. Multiple sclerosis: re-expression of a developmental gene in chronic lesions correlates with remyelination. Ann. Neurol. 1997;41:797–805
  33. Kuhlmann T, Lucchinetti C, Zettl UK, Bitsch A, Lassmann H, Brück W. Bcl-2-expressing oligodendrocytes in multiple sclerosis lesions. Glia. 1999;28:34–39
  34. Wolswijk G. Chronic stage multiple sclerosis lesions contain a relatively quiescent population of oligodendrocyte precursor cells. J. Neurosci. 1998;18:601–609
  35. Chang A, Nishiyama A, Peterson J, Prineas J, Trapp BD. NG2-positive oligodendrocyte progenitor cells in adult human brain and multiple sclerosis lesions. J. Neurosci. 2000;20:6404–6412
  36. Scolding N, Franklin R, Stevens S, Heldin C-H, Compston A, Newcombe J. Oligodendrocyte progenitors are present in the normal adult human CNS and in the lesions of multiple sclerosis. Brain. 1998;121:2221–2228
  37. Franklin RJM, Hinks GL. Understanding CNS remyelination: clues from developmental and regeneration biology. J. Neurosci. Res. 1999;58:207–213
  38. Brück W, Neubert K, Berger T, Weber JR. Clinical, radiological, immunological and pathological findings in inflammatory CNS demyelination—possible markers for an antibody-mediated process. Mult. Scler. 2001;7:173–177
  39. Barkhof F. Imaging of remyelination. Mult. Scler. 1997;3:129–132
  40. 't Hart BA, Bauer J, Muller H-J, Melchers B, Nicolay K, Brok H, et al.  Histopathological characterization of magnetic resonance imaging-detectable brain white matter lesions in a prı́mate model of multiple sclerosis. Am. J. Pathol. 1998;153:649–663
  41. Gareau PJ, Rutt BK, Karlik SJ, Mitchell JR. Magnetization transfer and multicomponent T2 relaxation measurements with histopathologic correlation in an experimental model of MS. J. Magn. Reson. Imaging. 2000;11:586–595
  42. Moore GRW, Leung E, MacKay AL, Vavasour IM, Whittall KP, Cover KS, et al.  A pathology-MRI study of the short-T2 component in formalin-fixed multiple sclerosis brain. Neurology. 2000;55:1506–1510
  43. Deloire-Grassin MSA, Brochet B, Quesson B, Delalande C, Dousset V, Canioni P, et al.  In vivo evaluation of remyelination in rat brain by magnetization transfer imaging. J. Neurol. Sci. 2000;178:10–16
  44. Bitsch A, Bruhn H, Vougioukas V, Stringaris A, Lassmann H, Frahm J, et al.  Inflammatory CNS demyelination: a comparison of biopsied lesion histopathology with quantitative proton magnetic resonance spectroscopy in vivo. Am. J. Neuroradiol. 1999;20:1619–1627
  45. Youl BD, Turano G, Miller DH, Towell AD, MacManus DG, Moore SG, et al.  The pathophysiology of acute optic neuritis. Brain. 1991;114:2437–2450
  46. Smith KJ, Blakemore WF, McDonald WI. The restoration of conduction by central remyelination. Brain. 1981;104:383–404
  47. van Walderveen MAA, Kamphorst W, Scheltens P, van Waesberghe JHTM, Ravid R, Valk J, et al.  Histopathologic correlate of hypointense lesions on T1-weighted spin-echo MRI in multiple sclerosis. Neurology. 1998;50:1282–1288
  48. van Waesberghe JHTM, Kamphorst W, De Groot CJA, van Walderveen MAA, Castelijns JA, Ravid R, et al.  Axonal loss in multiple sclerosis lesions: magnetic resonance imaging insights into substrates of disability. Ann. Neurol. 1999;46:747–754
  49. van Waesberghe JH, van Walderveen MA, Castelijns JA, Scheltens P, Lycklama A, Nijeholt GJ, et al.  Patterns of lesion development in multiple sclerosis: longitudinal observations with T1-weighted spin-echo and magnetization transfer MR. Am. J. Neuroradiol. 1998;19:675–683
  50. Bitsch A, Kuhlmann T, Stadelmann C, Lassmann H, Lucchinetti C, Brück W. A longitudinal MRI study of histopathologically defined hypointense multiple sclerosis lesions. Ann. Neurol. 2001;49:793–796
  51. Warrington AE, Asakura K, Bieber AJ, Ciric B, van Keulen V, Kaveri SV, et al.  Human monoclonal antibodies reactive to oligodendrocytes promote remyelination in a model of multiple sclerosis. Proc. Natl. Acad. Sci. U. S. A. 2000;97:6820–6825
  52. van Engelen BGM, Miller DJ, Pavelko KD, Hommes OR, Rodriguez M. Promotion of remyelination by polyclonal immunoglobulin in Theiler's virus-induced demyelination and in multiple sclerosis. J. Neurol. Neurosurg. Psychiatry. 1994;57(S):65–68
  53. Noseworthy JH, O'Brien PC, Weinshenker BG, Weis JA, Petterson TM, Erickson BJ, et al.  IV immunoglobulin does not reverse established weakness in MS. A double-blind, placebo-controlled trial. Neurology. 2000;55:1135–1143
  54. Moscarello MA, Mak B, Nguyen TA, Wood DD, Mastronardi F, Ludwin SK. Paclitaxel (Taxol) attenuates clinical disease in a spontaneously demyelinating transgenic mouse and induces remyelination. Mult. Scler. 2002;8:130–138
  55. Itoyama Y, Webster Hd, Richardson EP, Trapp BD. Schwann cell remyelination of demyelinated axons in spinal cord multiple sclerosis lesions. Ann. Neurol. 1983;14:339–346

PII: S0022-510X(02)00191-0

Journal of the Neurological Sciences
Volume 206, Issue 2 , Pages 181-185 , 15 February 2003

Article Tools

* Image Usage & Resolution